[ Price : $8.95]
FDA warns Centaur Pharmaceuticals about CGMP issues in its manufacturing of drugs at its facility in Maharashtra, India.[ Price : $8.95]
FDA says the deadline for submissions for the next cycle of the Advancing Real-World Evidence program is 9/30.[ Price : $8.95]
FDA publishes a draft guidance with recommendations for single-entity and fixed-combination antiretroviral drugs to be distributed...[ Price : $8.95]
FDA chief scientist Namandj Bumpus says the agency is looking to revamp its advisory committees to convene panels that will solici...[ Price : $8.95]
FDA revises form 356h: Application to Market a New or Abbreviated New Drug or Biologic for Human Use and form 1571: Investigationa...[ Price : $8.95]
Three drug and medical device industry trade associations comment positively on an FDA draft guidance on decentralized clinical tr...[ Price : $8.95]
FDA approves Taiho Oncologys Lonsurf (trifluridine and tipiracil) with bevacizumab for treating certain metastatic colorectal canc...[ Price : $8.95]
FDA converts a BD Respiratory Viral Panel from an emergency use authorization to a cleared 510(k) for detecting Covid-19, influenz...